Literature DB >> 8668171

Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.

E M Schwarz1, D Van Antwerp, I M Verma.   

Abstract

IkappaBalpha is a phosphoprotein that sequesters the NF-kappaB/Rel transcription factors in the cytoplasm by physical association. Following induction by a wide variety of agents, IkappaBalpha is further phosphorylated and degraded, allowing NF-kappaB/Rel proteins to translocate to the nucleus and induce transcription. We have previously reported that the constitutive phosphorylation site resides in the C-terminal PEST region of IkappaBalpha and is phosphorylated by casein kinase II (CKII). Here we show that serine 293 is the preferred CKII phosphorylation site. Additionally, we show compensatory phosphorylation by CKII at neighboring serine and threonine residues. Thus, only when all five of the serine and threonine residues in the C-terminal region of IkappaBalpha are converted to alanine (MutF), is constitutive phosphorylation abolished. Finally, we show that constitutive phosphorylation is required for efficient degradation of free IkappaBalpha, in that unassociated Mutf has a half-life two times longer than wild-type IkappaBalpha. A serine residue alone at position 293, as well as aspartic acid at this position, can revert the Mutf phenotype. Therefore, the constitutive CKII phosphorylation site is an integral part of the PEST region of IkappaBalpha, and this phosphorylation is required for rapid proteolysis of the unassociated protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668171      PMCID: PMC231350          DOI: 10.1128/MCB.16.7.3554

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Constitutive phosphorylation of I kappa B alpha by casein kinase II.

Authors:  C F Barroga; J K Stevenson; E M Schwarz; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

2.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

Review 3.  Rel/NF-kappa B/I kappa B story.

Authors:  S Miyamoto; I M Verma
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

4.  Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein.

Authors:  M S Rodriguez; I Michalopoulos; F Arenzana-Seisdedos; R T Hay
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B.

Authors:  I Alkalay; A Yaron; A Hatzubai; S Jung; A Avraham; O Gerlitz; I Pashut-Lavon; Y Ben-Neriah
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.

Authors:  J A DiDonato; F Mercurio; M Karin
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

Review 7.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

8.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.

Authors:  K Brown; S Gerstberger; L Carlson; G Franzoso; U Siebenlist
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

9.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.

Authors:  S C Sun; P A Ganchi; D W Ballard; W C Greene
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

10.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Authors:  K Brown; S Park; T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more
  52 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Authors:  S T Whiteside; J C Epinat; N R Rice; A Israël
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 4.  Molecular mechanisms in lymphocyte activation and growth.

Authors:  D W Ballard
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling.

Authors:  Kuljit Parhar; Jennifer Morse; Baljinder Salh
Journal:  Int J Colorectal Dis       Date:  2006-09-29       Impact factor: 2.571

6.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation.

Authors:  Amin Majdalawieh; Lei Zhang; Hyo-Sung Ro
Journal:  Mol Biol Cell       Date:  2007-01-03       Impact factor: 4.138

8.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Authors:  K Bender; M Göttlicher; S Whiteside; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice.

Authors:  E M Schwarz; C Badorff; T S Hiura; R Wessely; A Badorff; I M Verma; K U Knowlton
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.